期刊文献+

美托洛尔联合胺碘酮治疗室性心律失常的临床效果

下载PDF
导出
摘要 目的探讨美托洛尔联合胺碘酮用于室性心律失常治疗的临床效果。方法选取室性心律失常患者106例,随机分为对照组和观察组,每组53例,其中对照组采用胺碘酮治疗,观察组在对照组基础上加服美托洛尔。观察比较两组患者的临床治疗效果及不良反应发生情况。结果治疗后,两组患者的心率、收缩压、舒张压均较治疗前明显改善(P<0.05),而观察组改善幅度更大(P<0.05);观察组起效时间、窦性心率转复率和治疗总有效率均显著优于对照组(P<0.05);治疗期间,两组患者均未见严重不良反应。结论美托洛尔联合胺碘酮可有效改善室性心律失常患者的心肌功能、提高治疗效果,且无严重用药反应,可作为治疗室性心律失常的有效方式之一。
作者 何毅峰
机构地区 汝城县人民医院
出处 《当代医学》 2017年第3期119-121,共3页 Contemporary Medicine
  • 相关文献

参考文献6

二级参考文献56

  • 1赵顺芳,吴新华,尹雪艳,李利华.美托洛尔联用稳心颗粒治疗期前收缩患者临床观察[J].中国中西医结合急救杂志,2009,16(6):366-366. 被引量:10
  • 2Mclaughlin MG, Zimetbaum PJ. Electrocardiographic predictors of arrhythmic death. Ann Noninvasive Electrocardiol, 2006,11 ( 4 ) : 327-337.
  • 3Taylor E, Berger R, Hummel JD, et al. Analysis of the patterm of initiation of sustained ventricular arrhythmias in patients with implantable defibrillators. J Cardiovasc Electrophysiol, 2000,11 (7) :719-726.
  • 4Kokolis S, Clark LT, Kokolis R, et al. Ventricular arrhythmias and sudden cardiac death. Prog Cardiovasc Dis, 2006,48 ( 6 ) : 426-444.
  • 5SOS-KANTO. Cardroplonarg resuscitation by bystanders with chest compression only ( SOS-KANTO ) : an observational study. Lancet, 2007,369 ( 9565 ) : 920-926.
  • 6The AFFIRM Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med, 2002, 347 (23): 1825 -1833.
  • 7McBride BF,Min B,Kluger J,et al. An evaluation of the impact of oral magnesium tactare on the corrected QT interval of patients receiving Sotalol or Dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Ann Noninvasive Electrocardiol, 2006,11(2) :163-169.
  • 8Haraguchi R, Ashihara T, Namba T, et al. Transmural dispersion of repolarization determines scroll wave behavior during ventricular tachyarrhythmias[J]. Circ J, 2011,75 ( 1 ) 80 88.
  • 9Viswanathan P C, Rudy Y. Cellular arrhythmogenic effects of congenital and acquired long QT syndrome in the heterogene ous myocardium[J]. Circulation,2000,101(10) :1192-1198.
  • 10Johnson D M,de Jong M M J ,Crijns H J G M,et at. Reduced ventricular proarrhythmic potential of the novel combined ion channel blocker AZD1305 z,ersus dofetilide in dogs with remodeled hearts[J]. Circ Arrhythm Electrophysiol,2012,5 (1):201-209.

共引文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部